Skip to content
healthcare.dev

Viokace

NDC 73562-104, Pancrelipase, tablet, from Aimmune Therapeutics, Inc..

Product NDC
73562-104
Status
Listed
Labeler
Aimmune Therapeutics, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA022542
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73562-104 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PANCRELIPASE LIPASE10440 [USP'U]/1
  • PANCRELIPASE PROTEASE39150 [USP'U]/1
  • PANCRELIPASE AMYLASE39150 [USP'U]/1
Package NDCNDC-11Package
73562-104-10735620104101 BOTTLE in 1 CARTON (73562-104-10) / 100 TABLET in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/58bdb8de-582d-44e6-9b72-8d5a42fdf501
  • NADAC price for package 73562010410

    GET /v1/drugs/nadac/73562010410

Use it

Look up 73562-104 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73562-104 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73562-104. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.